Diagnosis and treatment of icteric hepatitis caused by erythropoietic protoporphyria: A case report

Diagnosis and treatment of icteric hepatitis caused by erythropoietic protoporphyria: A case report

Erythropoietic protoporphyria (EPP) is a rare inherited disease caused by partial deficiency activity of the enzyme ferrochelatase (FECH), resulting in excessive accumulation of protoporphyrin IX in erythrocyte and tissues. Here, we report a patient with photosensitive dermatitis and acute icteric h...

Full description

Bibliographic Details
Main Authors:	Hanqing Huang, Leiqin Cai, Xinhua Li, Shuru Chen
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2022-06-01
Series:	Liver Research
Subjects:	Erythropoietic protoporphyria (EPP) Inherited disease Photosensitive dermatitis Jaundice Ferrochelatase (FECH) Liver injury
Online Access:	http://www.sciencedirect.com/science/article/pii/S2542568422000216

Similar Items

Loss-of-Function Ferrochelatase and Gain-of-Function Erythroid-Specific 5-Aminolevulinate Synthase Mutations Causing Erythropoietic Protoporphyria and X-Linked Protoporphyria in North American Patients Reveal Novel Mutations and a High Prevalence of X-Linked Protoporphyria
by: Manisha Balwani, et al.
Published: (2013-01-01)

A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria
by: Manisha Balwani, et al.
Published: (2022-12-01)

Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria
by: Katelyn E. Madigan, et al.
Published: (2023-12-01)

Experimental and approved treatments for skin photosensitivity in individuals with erythropoietic protoporphyria or X-linked protoporphyria: A systematic review
by: Ida M. Heerfordt, et al.
Published: (2023-02-01)

Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria
by: Elena Di Pierro, et al.
Published: (2022-01-01)

Iron, Heme Synthesis and Erythropoietic Porphyrias: A Complex Interplay
by: Antoine Poli, et al.
Published: (2021-11-01)

Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
by: Anna-Elisabeth Minder, et al.
Published: (2023-04-01)

When the diagnosis is written in the DNA: a case of erythropoietic protoporphyria in a patient with a chromosome 18 deletion
by: Sara Rovaris, et al.
Published: (2023-09-01)

Management of erythropoietic protoporphyria with cholestatic liver disease: A case report
by: Antoine Poli, et al.
Published: (2023-12-01)

Development and content validation of a sunlight exposure diary in patients with erythropoietic protoporphyria
by: Susan D. Mathias, et al.
Published: (2023-11-01)

Heme Biosynthetic Gene Expression Analysis With dPCR in Erythropoietic Protoporphyria Patients
by: Francesca Granata, et al.
Published: (2022-07-01)

Protection from phototoxic injury during laparoscopic surgery in patients with erythropoietic protoporphyria
by: Konrad Pielaciński, et al.
Published: (2022-06-01)

Erythropoietic protoporphyria: case reports for clinical and therapeutic hints
by: Cristina Tumminelli, et al.
Published: (2023-11-01)

Development and Content Validation of Novel Patient-Reported Outcome Measures to Assess Disease Severity and Change in Patients with Erythropoietic Protoporphyria: The EPP Impact Questionnaire (EPIQ)
by: Mathias SD, et al.
Published: (2024-02-01)

Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria
by: Makiko Yasuda, et al.
Published: (2023-12-01)

Molecular Expression and Characterization of Erythroid-Specific 5-Aminolevulinate Synthase Gain-of-Function Mutations Causing X-Linked Protoporphyria
by: David F. Bishop, et al.
Published: (2013-01-01)

Absorption, metabolism, and excretion of [14C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers
by: Minoru Tsuda, et al.
Published: (2023-06-01)

A case of congenital erythropoietic porphyria without hemolysis
by: Arun K De, et al.
Published: (2013-01-01)

Acquired erythropoietic uroporphyria associated with clonal cytopenia of undetermined significance
by: Leah A. Swanson, MD, et al.
Published: (2023-02-01)

Iron Metabolism in the Disorders of Heme Biosynthesis
by: Andrea Ricci, et al.
Published: (2022-08-01)

Erythropoietic protoporphyria in pregnancy.
by: Madu, A, et al.
Published: (2006)

An Atypical Case of Congenital Erythropoietic Porphyria
by: Bénédicte Sudrié-Arnaud, et al.
Published: (2021-11-01)

Data on the frequency and causes of icteric interference in clinical chemistry laboratory tests
by: Anna E. Merrill, et al.
Published: (2022-02-01)

5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy
by: Richard Howley, et al.
Published: (2023-04-01)

Bullous lesions following phototherapy in a newborn
by: Marina Moura Toscano, et al.
Published: (2023-05-01)

The Associations between Erythropoietic Response with Inflammation Markers and Perfluorinated Chemicals in Hemodialysis Patients
by: Wen-Sheng Liu, et al.
Published: (2023-02-01)

Current trials in erythropoietic protoporphyria: are placebo controls ethical?
by: Jasmin Barman-Aksözen, et al.
Published: (2023-10-01)

A Survey on Generic Impersonal Structures in Brazilian Portuguese
by: Karina Gomes Bertolino
Published: (2023-09-01)

Late-onset Erythropoietic Protoporphyria Associated with Myelodysplastic Syndrome Treated with Azacitidine
by: Ai Yoshioka, et al.
Published: (2017-11-01)

KERANGKA KERJA PENILAIAN INVESTASI LINGKUNGAN (ENVIRONMENTAL PERFORMANCE APPRAISAL)
by: Sihar Tigor Benjamin Tambunan
Published: (2007-01-01)

Zinc supplementation improves heme biosynthesis in rats exposed to lead
by: Budi Santosa, et al.
Published: (2015-04-01)

Altering Tetrapyrrole Biosynthesis by Overexpressing <i>Ferrochelatases</i> (<i>Fc1</i> and <i>Fc2</i>) Improves Photosynthetic Efficiency in Transgenic Barley
by: Dilrukshi S. K. Nagahatenna, et al.
Published: (2020-09-01)

In Campylobacter jejuni, a new type of chaperone receives heme from ferrochelatase
by: Jordi Zamarreño Beas, et al.
Published: (2023-06-01)

Сase report of syphilitic hepatitis
by: Aibar Aginbay, et al.
Published: (2023-10-01)

Flavonoid 4,4′-dimethoxychalcone selectively eliminates senescent cells via activating ferritinophagy
by: Tianxiang Wang, et al.
Published: (2024-02-01)

Effects of Supplemental Drugs on Hexaminolevulinate (HAL)-Induced PpIX Fluorescence in Bladder Cancer Cell Suspensions
by: Kit Man Chan, et al.
Published: (2022-07-01)

Ein Freund, ein guter Freund
by: Csaba Győry

Severe Perinatal Presentations of Günther’s Disease: Series of 20 Cases and Perspectives
by: Claire Goudet, et al.
Published: (2024-01-01)

PB1998: AZACYTIDINE AND ALLOGENOUS STEM CELL TRANSPLANTATION IN LATE-ONSET ERYTHROPOIETIC PROTOPORPHYRIA
by: Daniel El Fassi, et al.
Published: (2023-08-01)

Two Novel Mutations in FECH in a Patient With Erythropoietic Protoporphyria: A Case Report
by: Qi Tan, et al.
Published: (2023-06-01)